Skip to content
The COVID Project
  1. Library
  2. Other federal health agencies
  3. AGY-FED-HEALTH-OTHER-021

Ex. AGY-FED-HEALTH-OTHER-021 Context (guidance or announcement) Primary source read

DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider's DEA-registered location during the COVID-19 public health emergency

Administering Certain CS in the parking lot of a healthcare provider's DEA-registered location during the COVID-19 public health emergency

Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213) · United States (federal); Drug Enforcement Administration, Diversion Control Division (Federal)

The COVID Project
Context, not an order

This record is guidance or an announcement kept for context. It is not counted among the orders in force.

The record

Jurisdiction
United States (federal); Drug Enforcement Administration, Diversion Control Division
Level
Federal
Authority
21 U.S.C. 822(e), 802(10); 21 C.F.R. 1301.12(a)
Issued
2020-07-28 July 28, 2020
Effective
2020-07-28
End
For the duration of the public health emergency (read as 2021-09-30)
In force
July 28, 2020 to Sept. 30, 2021
Quarters
2020 Q32020 Q42021 Q12021 Q22021 Q3
Limitation types
Health care ordersOther
Addressees
  • REMS-certified health care providers registered with DEA
Functions reached
  • CL clinical administration
  • SF premises (parking-lot care)
  • CB patients
Character
context
Collection
Other federal health agencies AGY-FED-HEALTH-OTHER

Operative words

The Food and Drug Administration (FDA) made an allowance for certain Risk Evaluation and Mitigation Strategies (REMS)-certified healthcare providers (HCPs) to provide medically supervised treatment in the patient's home during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. As an alternative to this, would DEA allow HCPs to administer REMS-designated controlled substances to patients in the parking lot at the HCPs' DEA-registered locations? Answer:... DEA will allow the administration of REMS-designated controlled substances in the parking lot of the registered location during the COVID-19 public health emergency, subject to the conditions stated.

Enforcement

Registration and dispensing requirements under 21 U.S.C. 822 and 842

Notes

Behavioral-health and pain clinics administering esketamine and similar REMS drugs moved administration outdoors.

Retrieval note

The answer's closing sentence is paraphrased from the document's conditions; the question is verbatim. Cite it as context and cite the underlying order, statute or emergency rule it describes as the instrument. (Bulletins whose operative text imposes a mandatory duty on licensees under the regulator's own authority are excluded from this downgrade and listed separately for review.)).